$VEEE
Twin Vee PowerCats, Co. Stock $veee

$veee Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000173112222001373 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$8.812M	$8.520M	$5.886M
YoY Change	113.98%	158.36%	83.5%
Cost Of Revenue	$5.478M	$5.072M	$3.452M
YoY Change	118.4%	156.0%	100.71%
Gross Profit	$3.334M	$3.447M	$2.434M
YoY Change	107.08%	161.92%	63.61%
Gross Profit Margin	37.84%	40.46%	41.36%
Selling, General & Admin	$707.3K	$637.7K	$682.3K
YoY Change	37.88%	129.26%	127.88%
% of Gross Profit	21.21%	18.5%	28.03%
Research & Development	$283.9K	$174.8K	$221.5K
YoY Change	364.78%
% of Gross Profit	8.52%	5.07%	9.1%
Depreciation & Amortization	$172.6K	$119.8K	$80.09K
YoY Change	455.14%	119.95%	72.16%
% of Gross Profit	5.18%	3.48%	3.29%
Operating Expenses	$4.191M	$3.919M	$3.483M
YoY Change	116.86%	173.48%	161.23%
Operating Profit	-$857.0K	-$472.0K	-$1.048M
YoY Change	165.7%	303.63%	-777.27%
Interest Expense	$52.88K	-$37.86K	-$125.3K
YoY Change	-186.83%	117.09%	607.79%
% of Operating Profit
Other Income/Expense, Net	-$30.15K	-$66.80K	-$143.2K
YoY Change	-50.37%	-139.81%	527.55%
Pretax Income	-$887.1K	-$538.8K	-$1.191M
YoY Change	131.45%	-1159.55%	-1002.86%
Income Tax
% Of Pretax Income
Net Earnings	-$887.1K	-$538.8K	-$1.191M
YoY Change	131.45%	-1159.53%	-1002.86%
Net Earnings / Revenue	-10.07%	-6.32%	-20.24%
Basic Earnings Per Share	-$0.10	-$0.08
Diluted Earnings Per Share	-$99.81K	-$76.97K	-$170.2K
COMMON SHARES
Basic Shares Outstanding	7.000M shares	7.000M shares	7.000M shares
Diluted Shares Outstanding		7.000M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.89M	$9.859M	$14.89M
YoY Change	51.87%	2324.62%	1258.11%
Cash & Equivalents	$19.98M	$5.911M	$5.061M
Short-Term Investments	$2.911M	$3.949M	$9.828M
Other Short-Term Assets	$1.510M	$755.3K	$1.042M
YoY Change	120.41%	17.01%	684.46%
Inventory	$4.393M	$4.370M	$3.213M
Prepaid Expenses
Receivables	$1.610K		$5.019K
Other Receivables	$368.1K	$286.9K	$286.9K
Total Short-Term Assets	$26.25M	$12.32M	$12.61M
YoY Change	67.9%	324.86%	388.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.775M	$4.363M	$3.433M
YoY Change	114.05%	165.22%	-4.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.911M	$2.951M	$2.980M
YoY Change	-5.88%
Other Assets	$25.00K	$25.00K	$25.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$8.975M	$8.700M	$7.896M
YoY Change	28.3%	154.91%	118.08%
TOTAL ASSETS
Total Short-Term Assets	$26.25M	$12.32M	$12.61M
Total Long-Term Assets	$8.975M	$8.700M	$7.896M
Total Assets	$35.22M	$21.02M	$20.50M
YoY Change	55.66%	232.98%	230.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.928M	$2.262M	$1.969M
YoY Change	14.21%	90.1%	111.96%
Accrued Expenses	$538.3K	$683.4K	$660.0K
YoY Change	9.37%	499.39%	15.49%
Deferred Revenue	$1.027M	$532.1K	$200.00
YoY Change	531.21%	181.58%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.996M	$3.976M	$3.123M
YoY Change	37.9%	94.49%	65.12%
LONG-TERM LIABILITIES
Long-Term Debt	$499.9K	$499.9K	$499.9K
YoY Change	-54.89%	-54.89%	-54.89%
Other Long-Term Liabilities	$949.5K	$1.048M	$1.146M
YoY Change	-28.95%	-26.66%	-24.64%
Total Long-Term Liabilities	$1.449M	$1.548M	$1.646M
YoY Change	-40.71%	-38.99%	-37.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.996M	$3.976M	$3.123M
Total Long-Term Liabilities	$1.449M	$1.548M	$1.646M
Total Liabilities	$5.445M	$5.524M	$4.769M
YoY Change	1.93%	20.58%	5.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.448M	-$3.748M	-$3.209M
YoY Change	268.48%	354.95%
Common Stock	$7.020K	$7.000K	$7.000K
YoY Change	0.29%	75.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.72M	$15.50M	$15.73M
YoY Change
Total Liabilities & Shareholders Equity	$35.22M	$21.02M	$20.50M
YoY Change	55.66%	232.98%	230.63%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$887.1K	-$538.8K	-$1.191M
YoY Change	131.45%	-1159.53%	-1002.86%
Depreciation, Depletion And Amortization	$172.6K	$119.8K	$80.09K
YoY Change	455.14%	119.95%	72.16%
Cash From Operating Activities	-$1.388M	-$46.58K	-$1.150M
YoY Change	85.46%	-74.8%	-705.42%
INVESTING ACTIVITIES
Capital Expenditures	-$584.7K	-$1.081M	$728.4K
YoY Change	-5.21%	568.43%	64.33%
Acquisitions
YoY Change
Other Investing Activities	$1.000M	$2.002M	$80.52K
YoY Change	-116.39%
Cash From Investing Activities	$415.3K	$921.0K	-$647.9K
YoY Change	-106.18%	-669.41%	46.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	15.04M	-25.24K	-$116.4K
YoY Change	-6.24%	-92.64%	-125.42%
NET CHANGE
Cash From Operating Activities	-1.388M	-46.58K	-$1.150M
Cash From Investing Activities	415.3K	921.0K	-$647.9K
Cash From Financing Activities	15.04M	-25.24K	-$116.4K
Net Change In Cash	14.07M	849.2K	-$1.914M
YoY Change	64.08%	-223.12%	-1035.84%
FREE CASH FLOW
Cash From Operating Activities	-$1.388M	-$46.58K	-$1.150M
Capital Expenditures	-$584.7K	-$1.081M	$728.4K
Free Cash Flow	-$803.4K	$1.035M	-$1.878M
YoY Change	510.29%	-4576.59%	641.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40623
	dei	Entity Central Index Key EntityCentralIndexKey	0001855509
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2021Q2	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
CY2021Q2	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery		usd
CY2021Q2	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments		usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	tvpc	Increase In Rightofuse Asset And Lease Liability IncreaseInRightofuseAssetAndLeaseLiability		usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q2	tvpc	Accrued Rebates AccruedRebates		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther		usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther		usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1417610
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
	dei	City Area Code CityAreaCode	(772)
	dei	Local Phone Number LocalPhoneNumber	429-2525
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	VEEE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7000000	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5910533	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6975302	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5137	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	997925	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2996960	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4369549	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1799769	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	247129	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	105500	usd
CY2022Q2	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	286922	usd
CY2021Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	286922	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	508203	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	903756	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	12320261	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	13073346	usd
CY2022Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	2951005	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	3067137	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4362758	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2883171	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1360883	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1550530	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	25000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	25000	usd
CY2022Q2	us-gaap	Assets Assets	21019907	usd
CY2021Q4	us-gaap	Assets Assets	20599184	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2262434	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1200861	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	272000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.86
	dei	Entity Registrant Name EntityRegistrantName	TWIN VEE POWERCATS CO.
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	683351	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	456814	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	532127	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14100	usd
CY2022Q2	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	115043	usd
CY2021Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	115043	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	382922	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	368602	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3975877	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2155420	usd
CY2022Q2	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	499900	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	499900	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1047806	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1244164	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5523583	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3899484	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7000000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19236979	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18710256	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3747655	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2017556	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15496324	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16699700	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21019907	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20599184	usd
CY2022Q2	us-gaap	Revenues Revenues	8519613	usd
CY2021Q2	us-gaap	Revenues Revenues	3297571	usd
	us-gaap	Revenues Revenues	14405613	usd
	us-gaap	Revenues Revenues	6505214	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	5072401	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1981427	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8524047	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3701164	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	3447212	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1316144	usd
	us-gaap	Gross Profit GrossProfit	5881566	usd
	us-gaap	Gross Profit GrossProfit	2804050	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	637744	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	278176	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1320065	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	577601	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	2793281	usd
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	1047244	usd
	us-gaap	Salaries And Wages SalariesAndWages	5047091	usd
	us-gaap	Salaries And Wages SalariesAndWages	1975414	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	193542	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	53182	usd
	us-gaap	Professional Fees ProfessionalFees	438281	usd
	us-gaap	Professional Fees ProfessionalFees	112208	usd
CY2022Q2	us-gaap	Depreciation Depreciation	119817	usd
CY2021Q2	us-gaap	Depreciation Depreciation	54475	usd
	us-gaap	Depreciation Depreciation	199909	usd
	us-gaap	Depreciation Depreciation	100998	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	174807	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	396352	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3919191	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1433077	usd
	us-gaap	Operating Expenses OperatingExpenses	7401698	usd
	us-gaap	Operating Expenses OperatingExpenses	2766221	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-471979	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-116933	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1520132	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	37829	usd
CY2022Q2	us-gaap	Other Income OtherIncome	2632	usd
	us-gaap	Other Income OtherIncome	3230	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-43716	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-17441	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-83556	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-35153	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	32901	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	32925	usd
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-31582	usd
CY2021Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-249499	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-49990	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-254600	usd
CY2021Q2	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	434724	usd
	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	434724	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-27038	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-112576	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-66803	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	167784	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-209967	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	144971	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-538782	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	50851	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1730099	usd
	us-gaap	Net Income Loss NetIncomeLoss	182800	usd
CY2022Q2	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	-0.08
CY2021Q2	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	0.01
	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	-0.25
	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	0.05
CY2022Q2	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	7000000	shares
CY2021Q2	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	4000000	shares
	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	7000000	shares
	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	4000000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1548840	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	131949	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1680789	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	50851	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1731640	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16699700	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	224832	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1191317	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	15733215	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	301891	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-538782	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15496324	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1730099	usd
	us-gaap	Net Income Loss NetIncomeLoss	182800	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	526723	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	199909	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100998	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-49990	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-224037	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	189647	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	192531	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-112576	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5137	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20540	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2569780	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	602838	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-395553	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	438892	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40566	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4369549	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1799769	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1061573	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	390867	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	226537	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-28928	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-182038	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-177184	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	518027	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	182194	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1196245	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5045	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2002591	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	80000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1809486	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	604990	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	273105	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-604990	usd
	us-gaap	Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment	141629	usd
	us-gaap	Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment	206293	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	608224	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	24300	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	311460	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-141629	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	114771	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1064769	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-485174	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6975302	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	891816	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5910533	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	406642	usd
	us-gaap	Interest Paid Net InterestPaidNet	73471	usd
	us-gaap	Interest Paid Net InterestPaidNet	97470	usd
	tvpc	Increase In Rightofuse Asset And Lease Liability IncreaseInRightofuseAssetAndLeaseLiability	655726	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_znNmKXz8DVAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zi01fX5bPvbc">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Cash Cash	5910533	usd
CY2021Q4	us-gaap	Cash Cash	6975302	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zu3Z0GPN39Tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zgAqVhA6eFE1">Concentrations of Credit and Business Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of trade receivables. Credit risk on trade receivables is mitigated as a result of the Company’s use of trade letters of credit, dealer floor plan financing arrangements, and the geographically diversified nature of the Company’s customer base. The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_c20220630_pp0p0" title="FDIC insured limit">250,000</span> are at risk. As of June 30, 2022 and December 31, 2021, the Company had $<span id="xdx_902_eus-gaap--CashUninsuredAmount_c20220630_pp0p0" title="FDIC uninsured amount">4,850,528</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="FDIC uninsured amount">6,725,302</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4850528	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	6725302	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	532127	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14100	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	189000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	396900	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	416745	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	437582	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1440227	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9499	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1430728	usd
	tvpc	Sharebased Compensation Arrangement By Granted Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementByGrantedSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2702733	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1285116	usd
CY2022Q2	us-gaap	Marketable Securities MarketableSecurities	3948930	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	6064097	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3997257	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1518947	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	372292	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	240256	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5020222	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3344303	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	657464	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461132	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4362758	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2883171	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	199909	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100998	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0036	pure
CY2021Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0036	pure
	tvpc	Schedule Of Leases Supplemental Balance Sheet Information ScheduleOfLeasesSupplementalBalanceSheetInformation	<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLeasesSupplementalBalanceSheetInformation_zXjvrHOcsNui" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases - Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt; text-align: left; text-indent: 0pt"><span id="xdx_8BD_zeZDwhWn3oGi" style="display: none">Schedule of leases supplemental balance sheet information</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20220630_zmFX3GcEHSjc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20211231_zpupi0fPBzte" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">June 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt; width: 56%; text-align: left; text-indent: 0pt">Operating lease ROU asset</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,360,883</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,550,530</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20220630_zwk3vqgojA5j" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20211231_zH1TGhKzIyIc" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td> </td> <td colspan="3" style="text-align: center">June 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt; text-align: left; text-indent: 0pt">Operating lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzDOh_zflbo92Ud3ij" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt; width: 56%; text-align: left; text-indent: 0pt">Current portion</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">382,922</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">368,602</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzDOh_ziJ1rDdWT7gd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt; text-align: left; text-indent: 0pt">Non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,047,806</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,244,164</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzDOh_zRqR894MFiW" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt; text-indent: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,430,728</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,612,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1360883	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1550530	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	382922	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	368602	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1047806	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1244164	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1430728	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1612766	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0036	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M1D
	us-gaap	Operating Lease Cost OperatingLeaseCost	195348	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	195348	usd
	us-gaap	Lease Cost LeaseCost	195348	usd
	us-gaap	Lease Cost LeaseCost	195348	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	319619	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	185402	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	84976	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	30000	usd
CY2022Q2	tvpc	Accrued Warranty AccruedWarranty	92990	usd
CY2021Q4	tvpc	Accrued Warranty AccruedWarranty	75000	usd
CY2021Q4	tvpc	Accrued Rebates AccruedRebates	60000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	43938	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	33852	usd
CY2022Q2	tvpc	Accrued Professional Fees AccruedProfessionalFees	81800	usd
CY2021Q4	tvpc	Accrued Professional Fees AccruedProfessionalFees	10225	usd
CY2022Q2	tvpc	Accrued Operating Expenses AccruedOperatingExpenses	60028	usd
CY2021Q4	tvpc	Accrued Operating Expenses AccruedOperatingExpenses	62335	usd
CY2022Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	683351	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	456814	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2171	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8892	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	9231	usd
CY2022Q2	us-gaap	Long Term Debt Maturing In Years Two And Three LongTermDebtMaturingInYearsTwoAndThree	9583	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	470023	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	499900	usd
CY2022Q2	us-gaap	Due From Affiliates DueFromAffiliates	93000	usd
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	5850	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	6922000	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	4273000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	377090	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	526723	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.0	pure
	tvpc	Expected Volatility Of Option Table Textblock ExpectedVolatilityOfOptionTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ExpectedVolatilityOfOptionTableTextblock_zBR86ZTjnrug" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholder's Equity (Details 1)"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8B6_zCqyOx5jhYEl" style="display: none">Schedule of Expected Volatility Of Option</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Outstanding</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining life</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; width: 34%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630_zH0K5H6OfBVl" style="width: 15%; text-align: right" title="Outstanding at beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">713,612</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630_zZFDiOUD2aX3" style="width: 15%; text-align: right" title="Outstanding at beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zHpDUoWpWkqi" title="Outstanding at end of period">9.54</span></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220630_pdd" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.86</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementByGrantedSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zvmJOPy80qGd" title="Granted">10.00</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220630_pdd" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0838">—</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0840">—</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20220630_zyORXqRygFo8" style="border-bottom: black 1pt solid; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,657</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220630_zSt2UD5O6EU6" style="border-bottom: black 1pt solid; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4.10</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_901_ecustom--SharebasedCompensationArrangementByForfeitedCanceledSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zpRyx4W85iL4" title="Forfeited">9.32</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630_zBtWQJIlEaEd" style="border-bottom: black 2.25pt double; text-align: right" title="Outstanding at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">981,955</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630_zXRCfRaYCryi" style="border-bottom: black 2.25pt double; text-align: right" title="Outstanding at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.82</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630_z2LGyH31wSAk" title="Outstanding at end of period">9.18</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options, June 30, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220630_pdd" style="border-bottom: black 2.25pt double; text-align: right" title="Exercisable at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">328,573</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220630_pdd" style="border-bottom: black 2.25pt double; text-align: right" title="Exercisable at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.93</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630_zFGAveFUzSx7" title="Exercisable at end of period">9.21</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table>
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	713612	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y6M14D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3657	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.10
	tvpc	Sharebased Compensation Arrangement By Forfeited Canceled Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementByForfeitedCanceledSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M25D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	981955	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.82
	tvpc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P9Y2M4D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	328573	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.93
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y2M15D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	663427	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1730099	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	182800	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4000000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0
CY2022Q2	us-gaap	Revenues Revenues	8519613	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	5072401	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3919191	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-471979	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-66803	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-538782	usd
CY2021Q2	us-gaap	Revenues Revenues	3297571	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1981427	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1433077	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-116933	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	167784	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	50851	usd
	us-gaap	Revenues Revenues	14405613	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8524047	usd
	us-gaap	Operating Expenses OperatingExpenses	7401698	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1520132	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-209967	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1730099	usd
	us-gaap	Revenues Revenues	6505214	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3701164	usd
	us-gaap	Operating Expenses OperatingExpenses	2766221	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	37829	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	144971	usd
	us-gaap	Net Income Loss NetIncomeLoss	182800	usd

Files In Submission

Name	View Source	Status
0001731122-22-001373-index-headers.html	Edgar Link	pending
0001731122-22-001373-index.html	Edgar Link	pending
0001731122-22-001373.txt	Edgar Link	pending
0001731122-22-001373-xbrl.zip	Edgar Link	pending
e3969_10-q.htm	Edgar Link	pending
e3969_ex31-1.htm	Edgar Link	pending
e3969_ex31-2.htm	Edgar Link	pending
e3969_ex32-1.htm	Edgar Link	pending
e3969_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
e3969_10-q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tvpc-20220630.xsd	Edgar Link	pending
tvpc-20220630_lab.xml	Edgar Link	unprocessable
tvpc-20220630_def.xml	Edgar Link	unprocessable
tvpc-20220630_pre.xml	Edgar Link	unprocessable
tvpc-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VEEE
Twin Vee PowerCats, Co. Stock $veee

2022 Q3 Form 10-Q Financial Statement

#000173112222001373 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VEEE Twin Vee PowerCats, Co. Stock $veee

2022 Q3 Form 10-Q Financial Statement

#000173112222001373 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VEEE
Twin Vee PowerCats, Co. Stock $veee